Related Experiment Video
Updated: Jun 26, 2026

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
Published on: August 21, 2017
Neuromyelitis optica
1William Penn Life Insurance Company of New York, 100 Quentin Roosevelt Blvd, Garden City, NY 11530, USA. rfeingold@gamerica.com
Abstract:
Neuromyelitis optica (NMO) is an uncommon central nervous system demyelinating disease that produces transverse myelitis and optic neuritis. Although commonly misdiagnosed as multiple sclerosis, a number of features can help differentiate the two entities, including the presence of NMO-IgG. Immunosuppressants are used to treat NMO, but the overall prognosis is poor.
Related Concept Videos
Multiple Sclerosis l: Introduction
Glaucoma: Overview
Angle Closure Glaucoma: Treatment
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Encephalitis ll: Pathophysiology
Myasthenia Gravis ll: Pathophysiology
